Targeted Feedback Reports to Improve Acute Coronary Syndromes (ACS) Care

Acute Coronary Syndromes Clinical Trial

Official title:

Personalized and Targeted Feedback in the ACTION-Registry-GWTG

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00952250
• Other study ID #: Pro00010526
• Status: Completed
• Phase: N/A
• First received: August 4, 2009
• Last updated: December 1, 2011
• Start date: February 2009
• Est. completion date: July 2011

Study information

• Verified date: December 2011
• Source: Duke University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

This project is designed to examine the impact of tailored feedback on site performance.

The investigators' objective is to evaluate whether a 'personalized and targeted' feedback, education and performance improvement intervention has a greater impact on adherence to recommended guidelines than standard feedback.

The investigators hypothesize that a site-specific report with centrally identified targets for improvement paired with target specific interventions will enable sites to quickly identify and prioritize salient problem areas, have ready access to an analysis of factors that underlie problems, and formulate an effective action plan. The investigators also hypothesize that those hospitals randomized to receive intervention will be more likely to improve their overall performance, as well as their target specific performance, during the period of observation in direct response to activated QI processes.

Outcomes:

The primary outcome is improvement in the overall composite of all metrics eligible for intervention regardless of their selection as targets.

The secondary outcome is improvement in the composite of targeted metrics.

Outcomes will be assessed in all participating sites, and in among relevant performance subgroups (low performers, academic centers, full service, and among medication versus process metrics).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 149
• Est. completion date: July 2011
• Est. primary completion date: July 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• hospitals participating in the ACTION Registry GWTG

Exclusion Criteria:

• sites with low volume of data submission (< 10 data forms in the past year)

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• Acute Coronary Syndromes

Intervention

Behavioral:
• Targeted Feedback Reports
Sites randomized to this arm will receive specialized feedback summarizing their adherence to the guidelines and suggestions on ways to improve performance.
• Targeted Feedback Report
Report designed to target areas for local hospital-specific improvement

Locations

Country	Name	City	State
United States	Duke University Health System	Durham	North Carolina

Sponsors (2)

Lead Sponsor	Collaborator
Duke University	Agency for Healthcare Research and Quality (AHRQ)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The primary outcome is improvement in the overall composite of all metrics eligible for intervention regardless of their selection as targets.		12 months	No
Secondary	The secondary outcome is improvement in the composite of targeted metrics.		12 months	No